Iovance Biotherapeutics

ISIN US4622601007

 | 

WKN A2DT49

Market cap (in EUR)
888 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 888 m
EPS, EUR -1.09
P/B ratio 1.4
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 152 m
Net income, EUR -344 m
Profit margin -226.84%

What ETF is Iovance Biotherapeutics in?

There are 22 ETFs which contain Iovance Biotherapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Iovance Biotherapeutics is the WisdomTree BioRevolution UCITS ETF USD Acc.
ETF Weight Investment focus Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) 0.01%
Equity
United States
Small Cap
55
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc 0.00%
Equity
United States
Multi-Factor Strategy
9
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc 0.01%
Equity
United States
Small Cap
46
UBS MSCI USA Select Factor Mix UCITS ETF USD acc 0.00%
Equity
United States
Multi-Factor Strategy
94
SPDR MSCI World Small Cap UCITS ETF 0.01%
Equity
World
Small Cap
1,436
Xtrackers Portfolio UCITS ETF 1C 0.00%
Equity
World
Multi-Asset Strategy
681
iShares Ageing Population UCITS ETF 0.05%
Equity
World
Health Care
Social/Environmental
Ageing Population
569
WisdomTree BioRevolution UCITS ETF USD Acc 0.59%
Equity
World
Health Care
Social/Environmental
Biotech
8
iShares Healthcare Innovation UCITS ETF 0.07%
Equity
World
Health Care
Social/Environmental
Innovation
934
Xtrackers Russell 2000 UCITS ETF 1C 0.02%
Equity
United States
Small Cap
1,875
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.01%
Equity
United States
Small Cap
182
UBS MSCI USA Select Factor Mix UCITS ETF USD dis 0.00%
Equity
United States
Multi-Factor Strategy
29
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc 0.00%
Equity
United States
Multi-Factor Strategy
31
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.00%
Equity
United States
Small Cap
1,825
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.06%
Equity
United States
Health Care
Biotech
46
iShares MSCI World Small Cap UCITS ETF 0.00%
Equity
World
Small Cap
6,377
iShares Nasdaq US Biotechnology UCITS ETF 0.06%
Equity
United States
Health Care
Biotech
750
SPDR MSCI USA Small Cap Value Weighted UCITS ETF 0.01%
Equity
United States
Small Cap
712
SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist) 0.01%
Equity
World
Small Cap
25
iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.00%
Equity
World
Small Cap
193
SPDR Russell 2000 US Small Cap UCITS ETF 0.02%
Equity
United States
Small Cap
4,010
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc 0.01%
Equity
United States
Small Cap
25
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.